With a celebrated local history of over 40 years, most recently on Hi Line Drive in the Design District and before that in ...

Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF) (“Avalon” or the “Company”) is pleased to announce the commencement ...

As biotechs faced investors at the J.P. Morgan Healthcare Conference this week, they emphasized agreement with the FDA on ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

Explore today's top 12 stock picks in telecom, defence, solar, railways, and infrastructure sectors for investment ...

VANCOUVER, BC, Jan. 14, 2026 /CNW/ – Artemis Gold Inc. (TSXV: ARTG) (“Artemis Gold” or the “Company”) announces production ...

Atara Biotherapeutics (NASDAQ: ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD).

Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 1 includes Ceragon Networks, Celldex, ...

A proposed data center campus will rise above Business Route 6 in Archbald while pumping in up to 3.3 million gallons of ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

AI, digital assets and more will remove longstanding barriers to change in banking in 2026. The leaders will seize the ...